Monocyte-derived dendritic cell (MoDC) differentiation

RP René Pfeifle
TR Tobias Rothe
NI Natacha Ipseiz
HS Hans U Scherer
SC Stephan Culemann
UH Ulrike Harre
JA Jochen A Ackermann
MS Martina Seefried
AK Arnd Kleyer
SU Stefan Uderhardt
BH Benjamin Haugg
AH Axel J Hueber
PD Patrick Daum
GH Gordon F Heidkamp
CG Changrong Ge
SB Sybille Böhm
AL Anja Lux
WS Wolfgang Schuh
IM Iryna Magorivska
KN Kutty S Nandakumar
EL Erik Lönnblom
CB Christoph Becker
DD Diana Dudziak
MW Manfred Wuhrer
YR Yoann Rombouts
CK Carolien A Koeleman
RT René Toes
TW Thomas H Winkler
RH Rikard Holmdahl
MH Martin Herrmann
SB Stephan Blüml
FN Falk Nimmerjahn
GS Georg Schett
GK Gerhard Krönke
request Request a Protocol
ask Ask a question
Favorite

MoDCs were differentiated from monocytes isolated from PBMCs (via their ability to bind to plastic surfaces) and were cultivated in RPMI supplemented with 5% FCS (Biochrom), 1% penicillin-streptomycin (Gibco), 1% l-glutamine (Gibco) 1 mM HEPES and 1 mM sodium pyruvate (Sigma) in the presence of 800 U/ml GM-CSF (Peprotech) and 500 U/ml IL-4 (Peprotech). Cells were fed on day 3 and day 5. Experiments were performed on day 6 by co-incubation of MoDCs with heat-aggregated ICs after pre-conditioning of MoDCs with 0.5 ng/ml LPS.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A